Article
Prevalence of PIK3CA mutations and the SNP rs17849079 in Arab breast cancer patients.
Cancer biology & therapy - 1 Oct 2013
Karakas Bedri, Colak Dilek, Kaya Namik, Ghebeh Hazem, Al-Qasem Abeer, Hendrayani Fawziah, Toulimat Mohamed, Al-Tweigeri Taher, Park Ben Ho, Aboussekhra Abdelilah
Abstract excerpt
Carcinomas initiate and progress due to genetic and epigenetic alterations in epithelial cells. However, recently, these alterations have also been reported in stromal fibroblasts. The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas. We analyzed the mutational frequency of PIK3CA of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
